Navigation Links
Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
Date:3/13/2008

"Obsessive compulsive disorder and social anxiety disorder are two very serious and debilitating anxiety disorders that affect millions of patients in the U.S. We are excited to be near the launch of a product that has been proven safe and effective for treating both of these conditions," said Robert M. Myers, Jazz Pharmaceuticals' President. "A comprehensive commercialization plan, including physician education, pricing and reimbursement and manufacturing and distribution, is in place. Jazz Pharmaceuticals' sales force of approximately 200 experienced professionals has been trained and is ready to promote LUVOX CR to psychiatrists for the treatment of OCD and SAD. We look forward to a successful launch."

Jazz Pharmaceuticals' sales representatives currently promote XYREM(R) (sodium oxybate) for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy to sleep specialists, neurologists and psychiatrists. XYREM net sales increased by 34 percent, from $29 million in 2006 to $39 million in 2007. XYREM net sales are expected to be in the range of $45 million to $55 million during 2008.

Jazz Pharmaceuticals projects sales of products in 2008 between $90 million and $120 million, with gross margin on net product sales of approximately 80 percent.

"2007 was a year of strong accomplishments, with increased sales and brand awareness for XYREM and the expansion of our commercial organization in preparation for the pending launch of LUVOX CR," added Mr. Myers.

Development-Stage Portfolio Updates

Jazz Pharmaceuticals announced that it has achieved more than 80 percent enrollment in the first of two ongoing Phase III clinical trials of JZP-6 (sodium oxybate) for the treatment of fibromyalgia syndrome. Enrollment in the first Phase III trial is expected to be completed during the next several months. Jazz Pharmaceuticals plans to announce top-line results from this Phase III clinical trial by year end. The second P
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
2. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
3. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
4. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
5. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
8. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
9. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
10. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
11. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Oregon (PRWEB) October 20, 2014 Succeed is ... of local companies who participated in the Every Body ... is a public awareness project that encourages workers to be ... Summer Step 10,000 Program, which concluded at the end of ... variety of cities and metro areas. Participating companies gave ...
(Date:10/20/2014)... DALLAS (PRWEB) October 20, 2014 It’s hard ... for many orphans and vulnerable children around the world, it’s ... by some people, many children are forced to walk barefoot ... for their families or play with their friends. , ... partnering with Air1 Radio in October to encourage ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently ... are the best Dedicated Server Hosting suppliers. Their ... to buy high quality hosting and save money ... of Top10BestSEOHosting.com says, “We believe that iPage and ... A lot of the global clients enjoy using ...
(Date:10/19/2014)... 20, 2014 Recently, Top10BestSEOHosting.com has ... that JustHost, GoDaddy and HostMonster are the best ... (Virtual Private Server) is the method of partitioning ... of which has the appearance and capabilities of ... why the site pays close attention to VPS ...
(Date:10/19/2014)... 2014 (HealthDay News) -- New stem cell-based research could ... new treatments, a new study suggests. Scientists used ... tissue in a lab dish. They then transplanted the ... intestinal disorders, according to the researchers. "This provides ... conditions that can cause intestinal failure, from genetic disorders ...
Breaking Medicine News(10 mins):Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2
... 21 /Xinhua-PRNewswire/ -- Mindray Medical,International Limited (NYSE: ... medical devices worldwide announced today that it will ... from October,29 to November 1., Mindray will ... core product,segments: patient monitoring & life support products, ...
... -- Total revenues of $1.8 billion, up 3.4% -- ... -- Cash flow from operations improved to $329 million ... per diluted share -- Agreement in principle reached regarding ... N.J., Oct. 21 , 2008-- Quest,Diagnostics Incorporated (NYSE: DGX ...
... test has been developed to measure the effectiveness of Aspirin Therapy, based ... the benefits of taking aspirin on a daily basis. The Aspirin ... the patient, resulting in further prevention of heart attacks. , ... Los ...
... iPhone and iPod Touch, is released today worldwide. Simple spoken instructions ... Resuscitation or how to act when someone is choking. , ... ... an application for iPhone and iPod Touch, is released today worldwide. ...
... Sexual Health Foundation (TWSHF) released an issue of the Women,s Sexual ... the Foundation frequently addresses with healthcare professionals, cancer patients and survivors. ... discussed prior to or after their cancer treatment relating to intimacy ... ...
... Mexico at fraction of the US cost. Andy got several fillings ... sitting. Overseas Dentistry, including dental implants abroad cost a ... ... (PRWEB) October 21, 2008 -- Andy Gobienko was eating a burger the ...
Cached Medicine News:Health News:Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair 2Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 2Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 3Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 4Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 5Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 6Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 7Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 8Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 9Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 10Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 11Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 12Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 13Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 14Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 15Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 16Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 17Health News:Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 2Health News:Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 3Health News:Save Lives with Your Mobile Phone - Doctor Releases First Aid Application for iPhone 2Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 2Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 3Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 4Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 2Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 3
(Date:10/20/2014)... DIEGO , Oct. 20, 2014 ... industry leader in bioactive lipid-targeted therapeutics, received official notification ... has been granted another key patent supporting its ... newly issued patent, European patent No. 2087002, claims ... substance in Lpath,s two lead compounds, iSONEP and ...
(Date:10/19/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... the Board of Directors of his decision to step down from ... of Severn Trent plc.  James will leave Shire at the end ... a new CFO immediately. Flemming Ornskov, Shire,s Chief Executive ... high-quality finance team at Shire. We are very grateful to him ...
(Date:10/17/2014)... HILL, N.C. , Oct. 17, 2014 /PRNewswire/ ... landscape, the Medical Affairs function has come across ... allocating resources efficiently and managing globalization.  ... Best Practices, LLC is dedicated to providing benchmarking ... The Medical Affairs Consortium is a service composed ...
Breaking Medicine Technology:Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Interim Chief Financial Officer James Bowling to Step Down 2Interim Chief Financial Officer James Bowling to Step Down 3Interim Chief Financial Officer James Bowling to Step Down 4Early Key Findings from the Medical Affairs Consortium Research 2
... MIAMI, Aug. 17 Stereotactic body radiotherapy (SBRT) is a highly ... in new research from The University of Texas in Houston, according ... of Miami and Palm Beach. , ( www.cyberkni f ... "This data confirms the established method of cancer treatment ...
... REHOVOT, Israel, August 17 D-Pharm announced today ... (approximately,$23M USD) to fund the Company,s late stage clinical stroke ... million and an Initial,Public Offering (IPO) of NIS 28 million. ... 133 NIS, 13% higher than the minimum price. The,company,s pre-money ...
Cached Medicine Technology:New Research Shows Effectiveness of Stereotactic Body Radiotherapy for Spinal Tumors 2D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 2D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 3
The CD Horizon M8 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
... Blackstone Spinal Fixation System ... system that provides an ... stabilization. It combines technical ... stability with a design ...
The CD Horizon Legacy Spinal System is part of the CD Horizon Spinal System designed for use in small stature patients. The posterior implants (hook and screws) are designed to fit patients in the ra...
... System Evolution offers the latest technology in ... spinal pathologies including degenerative lumbar spine, spondylolisthesis, ... also intended for the treaent of severe ... L5-S1 vertebra. Levels of pedicle screw fixation ...
Medicine Products: